Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

In the media

No-deal Brexit will impact on patient care

20 July 2018: Ash Soni, president of the Royal Pharmaceutical Society, spoke to Sky News about the potential consequences for patients in the event of a “no-deal” Brexit.

“We are worried that there may be shortages of medicines as a consequence of this,” Soni said. “We need to be much clearer about where we are in the whole process and what is happening. Our concern is that we may have a shortage of medicines and that will have a direct impact on patient care.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205216

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.